Cargando…

Visual field loss in schizophrenia: evaluation of magnocellular pathway dysfunction in schizophrenic patients and their parents

PURPOSE: We sought to evaluate the visual pathway deficits in schizophrenic patients, compared with their parents and healthy controls, using Matrix frequency doubling technology (FDT) perimetry. Matrix FDT is an ophthalmic test used to detect visual field loss. METHOD: A total of 13 patients, 13 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gracitelli, Carolina Pelegrini Barbosa, Vaz de Lima, Fabiana Benites, Bressan, Rodrigo A, Paranhos, Augusto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686534/
https://www.ncbi.nlm.nih.gov/pubmed/23807827
http://dx.doi.org/10.2147/OPTH.S43897
_version_ 1782273791929352192
author Gracitelli, Carolina Pelegrini Barbosa
Vaz de Lima, Fabiana Benites
Bressan, Rodrigo A
Paranhos, Augusto
author_facet Gracitelli, Carolina Pelegrini Barbosa
Vaz de Lima, Fabiana Benites
Bressan, Rodrigo A
Paranhos, Augusto
author_sort Gracitelli, Carolina Pelegrini Barbosa
collection PubMed
description PURPOSE: We sought to evaluate the visual pathway deficits in schizophrenic patients, compared with their parents and healthy controls, using Matrix frequency doubling technology (FDT) perimetry. Matrix FDT is an ophthalmic test used to detect visual field loss. METHOD: A total of 13 patients, 13 parents, and 12 healthy controls were enrolled in the study. Participants were subjected to Matrix FDT perimetry in a single test session. We analyzed the mean deviation for each eye and used a generalized estimated equation to evaluate differences among the groups and correct the dependency between the eyes. RESULTS: The global mean deviation (presented as the mean of both eyes) was significantly lower in the schizophrenic patients than in their parents or controls. Analysis of the general sensitivity of the fibers crossing the optic chiasm showed a difference between the groups (P = 0.006), indicating that the sensitivity of the fibers crossing the optic chiasm was lower than those which did not cross. But when we analyzed the specific groups, the difference between the fibers was not considerable. Comparison of the right and left hemispheres showed that general sensitivity was lower for the left hemisphere, but when we analyzed specific groups, the difference was not significant (P = 0.29). CONCLUSION: These findings are suggestive of a lower global sensitivity in schizophrenic patients and their parents compared with controls. This difference may be an endophenotype of schizophrenia. The present study adds to a growing body of research on early-stage visual processing deficits in schizophrenia.
format Online
Article
Text
id pubmed-3686534
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-36865342013-06-27 Visual field loss in schizophrenia: evaluation of magnocellular pathway dysfunction in schizophrenic patients and their parents Gracitelli, Carolina Pelegrini Barbosa Vaz de Lima, Fabiana Benites Bressan, Rodrigo A Paranhos, Augusto Clin Ophthalmol Original Research PURPOSE: We sought to evaluate the visual pathway deficits in schizophrenic patients, compared with their parents and healthy controls, using Matrix frequency doubling technology (FDT) perimetry. Matrix FDT is an ophthalmic test used to detect visual field loss. METHOD: A total of 13 patients, 13 parents, and 12 healthy controls were enrolled in the study. Participants were subjected to Matrix FDT perimetry in a single test session. We analyzed the mean deviation for each eye and used a generalized estimated equation to evaluate differences among the groups and correct the dependency between the eyes. RESULTS: The global mean deviation (presented as the mean of both eyes) was significantly lower in the schizophrenic patients than in their parents or controls. Analysis of the general sensitivity of the fibers crossing the optic chiasm showed a difference between the groups (P = 0.006), indicating that the sensitivity of the fibers crossing the optic chiasm was lower than those which did not cross. But when we analyzed the specific groups, the difference between the fibers was not considerable. Comparison of the right and left hemispheres showed that general sensitivity was lower for the left hemisphere, but when we analyzed specific groups, the difference was not significant (P = 0.29). CONCLUSION: These findings are suggestive of a lower global sensitivity in schizophrenic patients and their parents compared with controls. This difference may be an endophenotype of schizophrenia. The present study adds to a growing body of research on early-stage visual processing deficits in schizophrenia. Dove Medical Press 2013 2013-05-29 /pmc/articles/PMC3686534/ /pubmed/23807827 http://dx.doi.org/10.2147/OPTH.S43897 Text en © 2013 Gracitelli et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Gracitelli, Carolina Pelegrini Barbosa
Vaz de Lima, Fabiana Benites
Bressan, Rodrigo A
Paranhos, Augusto
Visual field loss in schizophrenia: evaluation of magnocellular pathway dysfunction in schizophrenic patients and their parents
title Visual field loss in schizophrenia: evaluation of magnocellular pathway dysfunction in schizophrenic patients and their parents
title_full Visual field loss in schizophrenia: evaluation of magnocellular pathway dysfunction in schizophrenic patients and their parents
title_fullStr Visual field loss in schizophrenia: evaluation of magnocellular pathway dysfunction in schizophrenic patients and their parents
title_full_unstemmed Visual field loss in schizophrenia: evaluation of magnocellular pathway dysfunction in schizophrenic patients and their parents
title_short Visual field loss in schizophrenia: evaluation of magnocellular pathway dysfunction in schizophrenic patients and their parents
title_sort visual field loss in schizophrenia: evaluation of magnocellular pathway dysfunction in schizophrenic patients and their parents
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686534/
https://www.ncbi.nlm.nih.gov/pubmed/23807827
http://dx.doi.org/10.2147/OPTH.S43897
work_keys_str_mv AT gracitellicarolinapelegrinibarbosa visualfieldlossinschizophreniaevaluationofmagnocellularpathwaydysfunctioninschizophrenicpatientsandtheirparents
AT vazdelimafabianabenites visualfieldlossinschizophreniaevaluationofmagnocellularpathwaydysfunctioninschizophrenicpatientsandtheirparents
AT bressanrodrigoa visualfieldlossinschizophreniaevaluationofmagnocellularpathwaydysfunctioninschizophrenicpatientsandtheirparents
AT paranhosaugusto visualfieldlossinschizophreniaevaluationofmagnocellularpathwaydysfunctioninschizophrenicpatientsandtheirparents